Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have signed a Memorandum of Understanding which ...

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

Moderna, Inc. (NASDAQ:MRNA) has announced updates demonstrating substantial R&D investment and progress in the UK, two years ...

The Social Institute, which equips students, families, and educators to navigate learning & well-being in a tech-fueled world, today released its fifth annual Student Insights Report on how social ...

But election vote tallies don't tell the whole story. Trump 2.0 is a manifestation of monumental changes in American ...

A trusted partner to 19 of the top 20 pharmaceutical companies, Medidata continues to break ground with new categories of critical patient-centric experiences, seamlessly integrating AI into its suite ...

The anti-Trump media seems partially paralyzed following President Donald Trump’s reelection last November and particularly ...

After contending with another year of high food and labor costs, financially stressed consumers, and fierce competition, U.S. restaurant operators are approaching 2025 with a focus on engaging more ...

Dozens of Alberta scientists, doctors and researchers have penned an open letter calling on the Alberta government to reject ...

Construction is now complete on the Moderna Innovation and Technology Centre (MITC), the pharma firm’s new research, ...

Investors are assessing China's instant retaliation to Trump's additional tariffs, amid worries about the risk of a trade war ...